Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 43.94
-0.54 (-1.21%)
At close: May 8, 2026
Bright Eye Hospital Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -10.35 | -60.92 | -101.86 | 267.91 | 20.57 | 93.89 |
Depreciation & Amortization | 333.2 | 329.36 | 315.75 | 273.82 | 214.82 | 177.71 |
Other Amortization | 90.11 | 93.95 | 83.64 | 68.89 | 51.99 | 42.89 |
Loss (Gain) From Sale of Assets | -0 | -0 | 0.93 | -0.06 | -0.56 | -0.93 |
Asset Writedown & Restructuring Costs | 11.17 | 8.79 | 6 | 0.47 | 2.12 | 8.62 |
Loss (Gain) From Sale of Investments | 10.89 | 10.17 | 3.51 | -78.29 | -12.6 | -9.47 |
Provision & Write-off of Bad Debts | - | 1.34 | -0.22 | 3.37 | 1.59 | - |
Other Operating Activities | 25.28 | 94.8 | 98.18 | 88.57 | 60.4 | 52.47 |
Change in Accounts Receivable | -4.24 | -4.24 | 4.04 | -23.18 | -13.26 | -5.11 |
Change in Inventory | -57.14 | -57.14 | 2.28 | -45.68 | -18.95 | -12.18 |
Change in Accounts Payable | 124.31 | 124.31 | -24.32 | 63.97 | 18.09 | 13.41 |
Change in Other Net Operating Assets | - | - | - | -3.24 | - | 1.63 |
Operating Cash Flow | 527.67 | 544.86 | 382.43 | 614.46 | 319.3 | 359.42 |
Operating Cash Flow Growth | 16.90% | 42.47% | -37.76% | 92.44% | -11.16% | 57.98% |
Capital Expenditures | -205.88 | -226.41 | -542.86 | -626.87 | -327.99 | -254.8 |
Sale of Property, Plant & Equipment | 4.68 | 4.84 | 1.45 | 0.22 | 1.02 | 1.76 |
Cash Acquisitions | -91.85 | -25.05 | -5 | 88.53 | - | -168.7 |
Investment in Securities | -123.62 | -202.13 | -8.63 | -29.24 | -274.91 | -7.6 |
Other Investing Activities | 2.02 | 1.56 | 1.66 | -1.02 | - | - |
Investing Cash Flow | -414.66 | -447.19 | -553.38 | -568.38 | -601.88 | -429.47 |
Long-Term Debt Issued | - | 198.5 | 550.13 | 282.8 | 202.5 | 110 |
Total Debt Issued | 260.24 | 198.5 | 550.13 | 282.8 | 202.5 | 110 |
Short-Term Debt Repaid | - | - | - | - | - | -0.58 |
Long-Term Debt Repaid | - | -415.88 | -579.31 | -391.52 | -259.13 | -149.15 |
Total Debt Repaid | -185.25 | -415.88 | -579.31 | -391.52 | -259.13 | -149.73 |
Net Debt Issued (Repaid) | 75 | -217.38 | -29.18 | -108.72 | -56.63 | -39.73 |
Issuance of Common Stock | - | - | - | - | 1,152 | - |
Repurchase of Common Stock | - | - | - | -29.98 | - | - |
Common Dividends Paid | -18.93 | -17.75 | -77.97 | -27.63 | -9.04 | -4.55 |
Other Financing Activities | -235.03 | -4.27 | -47.62 | - | -47.94 | - |
Financing Cash Flow | -178.97 | -239.4 | -154.78 | -166.33 | 1,038 | -44.28 |
Foreign Exchange Rate Adjustments | 0.02 | 0.02 | 0.1 | -0.41 | -0.29 | -0 |
Net Cash Flow | -65.94 | -141.72 | -325.63 | -120.65 | 755.46 | -114.33 |
Free Cash Flow | 321.79 | 318.45 | -160.43 | -12.41 | -8.68 | 104.62 |
Free Cash Flow Growth | 467.09% | - | - | - | - | 29.30% |
Free Cash Flow Margin | 11.19% | 11.38% | -5.99% | -0.46% | -0.50% | 6.12% |
Free Cash Flow Per Share | 2.17 | 2.14 | -1.07 | -0.08 | -0.07 | 0.94 |
Cash Income Tax Paid | 71.16 | 83.55 | 139.54 | 96.41 | 58.08 | 65.41 |
Levered Free Cash Flow | 263.74 | 208.65 | -172.77 | 78.63 | 1.6 | 66.15 |
Unlevered Free Cash Flow | 263.74 | 220.73 | -162.16 | 125.29 | 37.58 | 96.43 |
Change in Working Capital | 67.36 | 67.36 | -23.5 | -10.23 | -19.03 | -5.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.